ARCHIVES

Trials show No Advantage for ABMT In Breast Cancer; Should Insurers Pay?

This article is from The Cancer Letter archive.

Vol. 25 No. 15 | April 16, 1999

Download PDF Visit The Full Archive

Related Articles

Surgery Without Radiation Found Inadequate for DCIS

December 26, 2003

Blistering Resignation Letters Declare CPRIT Outside Mainstream of Science

October 12, 2012

FDA Codifies Rules For Expanded Access, Charging For Drugs In Clinical Trials.

December 22, 2006

Scientific Process

September 25, 1998

Alan Rabson Named Acting NCI Director

October 5, 2001

DCT Advisors Okay Two New RFA Concepts In Clinical Research, Biodiversity Groups

November 8, 1991